(257 days)
No
The summary describes statistical analysis and visualization of ultrasound data, but does not mention AI or ML algorithms.
No
The device is described as a software device intended to visualize and analyze statistical distributions of backscattered signals from tissue, providing conventional B-mode and color-mapped US-mode images for viewing and displaying backscatter statistical values. Its intended use is for primary diagnostic interpretation, not for treatment or therapy.
No
The device is intended to visualize and analyze statistical distributions of backscattered signals from tissue, but the documentation explicitly states that "The US-mode images displayed on AmCAD-US must not be used alone for primary diagnostic interpretation." This indicates it's a tool for analysis and visualization, not a standalone diagnostic device.
Yes
The device description explicitly states "AmCAD-US... is a software package". It processes data from an external, FDA-cleared ultrasound system and provides visualization and analysis, without including any hardware components itself.
Based on the provided information, AmCAD-US is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: IVD devices are used to examine specimens derived from the human body (like blood, urine, tissue samples) in vitro (outside the body) to provide information for diagnosis, monitoring, or screening.
- AmCAD-US Function: AmCAD-US processes backscattered signals from ultrasound, which is an in vivo (within the body) imaging modality. It analyzes data obtained directly from the patient's body using an ultrasound system.
- Intended Use: The intended use clearly states it visualizes statistical distributions of backscattered signals echoed by tissue compositions in the body. It does not involve the analysis of specimens taken from the body.
- Device Description: The description reinforces that it quantifies and visualizes backscattered statistics contained in ultrasound image data obtained from an FDA-cleared general purpose ultrasound system. This data is generated in vivo.
Therefore, AmCAD-US falls under the category of medical imaging software, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
AmCAD-US is a software device intended to visualize the statistical distributions of backscattered signals echoed by tissue compositions in the body. The backscattered signals are subject to the RF or Envelope data made available by an FDA-cleared general-purpose ultrasound system. The US-mode images displayed on AmCAD-US must not be used alone for primary diagnostic interpretation.
Product codes (comma separated list FDA assigned to the subject device)
LLZ
Device Description
AmCAD-US (model number 1.0) is intended to visualize and analyze the statistical distributions of backscattered signals echoed by tissue compositions in the body. AmCAD-US, which uses the proprietary technology and algorithms, is a software package designed to quantify and visualize the backscattered statistics contained in ultrasound image data obtained from an FDA-cleared general purpose ultrasound system. The device provides dual mode images, including conventional B-mode ultrasound image in gray scale and color-mapped US (ultrasound structure) mode image. The US-mode provides a means for viewing and displaying the backscatter statistical values. The device uses parametric model or nonparametric statistics that best describes the distribution curve of the backscattered signals. The parameters vary by the US method (backscattered statistics) selected. The preferences include options to set the parameters mapped onto the image and US method options applied to the data. The user can also select a specific region of interest (ROI) on the image for quantification analysis. The histogram view of the data provides a different view to accommodate the variation between tissue and tissue states. AmCAD-US has a data export function to record and save the analysis results. Note that the US-mode images displayed on AmCAD-US must not be used alone for primary diagnostic interpretation.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
Body / Tissue compositions
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Verification Tests: AmCad BioMed Corporation has conducted the software verification tests, including software unit test, software integration test, and software system test, to evaluate the safety and effectiveness of AmCAD-US. The software verification testing was performed to ensure that AmCAD-US meets all functional and specifications for its indication for use.
Non-clinical Validation Tests:
Phantom Study: AmCAD-US was applied to cell phantoms with different concentrations of one cell type and with different constitutions of mixed cell types. The results demonstrate the utility of the device in analyzing various cell compositions.
Animal Study: AmCAD-US was applied on 6 rats with liver fibrosis induced by dimethylnitrosamine (DMN) injection. The results demonstrate a strong correlation between the backscattered statistics provided by the device and the dosage of DMN injections, and the utility of the device in analyzing the variation of the tissue compositions in small animals.
Human tissue validation study: Two common ultrasound scanning modes (thyroid and abdomen) were applied. Two different FDA-cleared ultrasound systems were used. The result indicated that the device could be applied to various tissue parts in the human body and can be used with RF/Envelop data provided by various FDA-cleared ultrasound systems.
Clinical Validation Tests: The subject of this 510(k) notification, AmCAD-US, did not require clinical studies to support safety and effectiveness of the software.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
Image /page/0/Picture/1 description: The image shows the seal of the U.S. Department of Health and Human Services. The seal features a stylized caduceus, a symbol often associated with medicine and healthcare, on the right side. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus. The seal is black and white.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
May 30, 2017
AmCad BioMed Corporation % Chiu S. Lin, Ph.D. President Lin & Associates, LLC 5614 Johnson Avenue BETHESDA MD 20817
Re: K162574
Trade/Device Name: AmCAD-US Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: April 27, 2017 Received: April 28, 2017
Dear Dr. Lin:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
For
Robert Ochs. Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K162574
Device Name AmCAD-US
Indications for Use (Describe)
AmCAD-US is a software device intended to visualize the statistical distributions of backscattered signals echoed by tissue compositions in the body. The backscattered signals are subject to the RF or Envelope data made available by an FDA-cleared general-purpose ultrasound system. The US-mode images displayed on AmCAD-US must not be used alone for primary diagnostic interpretation.
Type of Use (Select one or both, as applicable)
| Prescription Use (Part 21 CFR 801 Subpart D) | |
|---|---|
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo and contact information for AmCad BioMed Corporation. The logo features a blue stylized "A" with a circle inside. The text includes the company name in both Chinese and English, followed by the address: FL.3, NO.167, Fu Hsing N. RD., Taipei 105, Taiwan, ROC. The telephone number is +886-2-27136227 and the fax number is +886-2-27152181.
510(k) Summary of Safety and Effectiveness
This 510(k) summary of safety and effectiveness information is submitted as part of the Premarket Notification in compliance with requirements of CFR Part 807, Subpart E and Section 807.92
1.1 Identification of Submitter:
| Submitter: | AmCad BioMed Corporation |
|---|---|
| Address: | FL.3, NO.167, Fu Hsing N. RD., Taipei 105, Taiwan, R.O.C. |
| Phone: | 886-2-2713-6227 |
| Fax: | 886-2-2715-2181 |
| Contact: | Jack Yang |
| Title: | Vice President |
| Phone: | 886-2-2713-6227 ext.2358 |
| Fax: | 886-2-2715-2181 |
| Email: | jack.yang@amcad.com.tw |
| Manufacturer: | AmCad BioMed Corporation |
| US Agent and Contact: | Chiu S. Lin, Ph.D. |
| Lin & Associates, LLC | |
| Address: | 5614 Johnson Avenue |
| Bethesda, MD 20817 | |
| Phone: | (0) 301-591-3895 |
| E-mail: | cslin@lin-associates.com |
- April 27, 2017 Date prepared:
1.2 Identification of Product
| Device Trade Name: | AmCAD-US |
|---|---|
| Model number: | 1.0 |
| Common and Usual Name: | Medical Image Processing and Analysis Software |
| Device Classification Name: | Picture Archiving and Communications System |
| Regulation Number: | 21 CFR 892.2050 |
4
Image /page/4/Picture/0 description: The image shows the logo and contact information for AmCad BioMed Corporation. The logo features a blue stylized "A" with a circle inside. The text includes the company name in both Chinese and English, followed by the address: FL.3, NO.167, Fu Hsing N. RD., Taipei 105, Taiwan, ROC. The telephone number is +886-2-27136227 and the fax number is +886-2-27152181.
| Classification Product Code: | LLZ |
|---|---|
| Classification: | Class II |
| Classification Panel: | Radiology Devices |
| Manufacturer: | AmCad BioMed Corporation |
1.3 Predicate Device
This subject software medical device is substantially equivalent to the devices listed below:
Primary Predicate Device Model: Q LAB Quantification Software.
Manufacturer: Philips Ultrasound, Inc.
510(k) Number: K021966, cleared on July 02, 2002.
In terms of technology, the reference device is listed below. Model: The software used on Volcano IVUS System. Manufacturer: Volcano Therapeutics, Inc. 510(k) Number: K042188, cleared on November 10, 2004.
1.4 Device Description
AmCAD-US (model number 1.0) is intended to visualize and analyze the statistical distributions of backscattered signals echoed by tissue compositions in the body. AmCAD-US, which uses the proprietary technology and algorithms, is a software package designed to quantify and visualize the backscattered statistics contained in ultrasound image data obtained from an FDA-cleared general purpose ultrasound system. The device provides dual mode images, including conventional B-mode ultrasound image in gray scale and color-mapped US (ultrasound structure) mode image. The US-mode provides a means for viewing and displaying the backscatter statistical values. The device uses parametric model or nonparametric statistics that best describes the distribution curve of the backscattered signals. The parameters
5
Image /page/5/Picture/0 description: The image shows the logo and contact information for AmCad BioMed Corporation. The logo features a stylized blue "A" with a white circle inside. The text includes the company name in both Chinese and English, followed by the address: FL.3, NO.167, Fu Hsing N. RD., Taipei 105, Taiwan, ROC. The telephone number is +886-2-27136227 and the fax number is +886-2-27152181.
vary by the US method (backscattered statistics) selected. The preferences include options to set the parameters mapped onto the image and US method options applied to the data. The user can also select a specific region of interest (ROI) on the image for quantification analysis. The histogram view of the data provides a different view to accommodate the variation between tissue and tissue states. AmCAD-US has a data export function to record and save the analysis results. Note that the US-mode images displayed on AmCAD-US must not be used alone for primary diagnostic interpretation.
1.5 Indications for Use
AmCAD-US is a software device intended to visualize and analyze the statistical distributions of backscattered signals echoed by tissue compositions in the body. The backscattered signals are subject to the RF or Envelope data made available by an FDA-cleared general-purpose ultrasound system. The US-mode images displayed on AmCAD-US must not be used alone for primary diagnostic interpretation.
1.6 Comparison with Predicate Devices
The proposed device is specifically intended for use as a PACS software device for viewing and quantifying the ultrasound image data and is substantially equivalent to the predicate, Q LAB Quantification Software, K021966, with the same intended use for viewing and quantifying ultrasound image data. They both provide statistical analysis of the intensity data or the image content obtained from the ultrasound machine. Both devices are classified as Picture Archiving and Communication System, 21 CFR 892.2050. Minor technological characteristics differences do not raise any new questions of safety and effectiveness. In terms of technology, the reference device is the software used on the Volcano IVUS system.
The comparison table 1.6.1 between our device and the predicate devices and reference device is provided below:
6
Image /page/6/Picture/0 description: The image contains the logo of AmCad BioMed Corporation. The logo consists of a blue stylized letter 'A' with a circle at the top, followed by the company name in both Chinese and English. The Chinese characters are '安克生醫股份有限公司', and the English name is 'AmCad BioMed Corporation'.
| Device | Proposed Device | Primary Predicate Device | Reference Device |
|---|---|---|---|
| AmCAD-US | Q LAB Quantification Software | The software used on Volcano | |
| IVUS System | |||
| Manufacturer | AmCad BioMed Corp. | Philips Ultrasound, Inc. | Volcano Therapeutics, Inc. |
| 510(k) Number | Pending | K021966 | K042188 |
| Device Common | |||
| Name | Picture archiving and | ||
| communications system | Same | Ultrasonic pulsed echo imaging | |
| system and Picture archiving | |||
| and communications system | |||
| Regulation | |||
| Number | 21 CFR 892.2050 - Class II | Same | 21 CFR 892.1560 - Class II |
| Regulation Name | Picture archiving and | ||
| communications system | Same | Ultrasonic pulsed echo imaging | |
| system (892.1560) | |||
| Product Code | LLZ | LLZ | IYO |
| Indications for | |||
| Use/Intended Use | AmCAD-US is a software | ||
| device intended to visualize | |||
| and quantify the statistical | |||
| distributions of | |||
| backscattered signals | |||
| echoed by tissue | |||
| compositions in the body. | |||
| The US-mode images | |||
| displayed on AmCAD-US | |||
| must not be used alone for | |||
| primary diagnostic | |||
| interpretation. | |||
| The software device | |||
| provides color-coded | QLAB Quantification software is | ||
| a software application package. | |||
| It is designed to view and | |||
| quantify image data acquired on | |||
| Philips Healthcare ultrasound | |||
| products. | |||
| The Q LAB software provides a | |||
| means for creating region of | |||
| interest figures overlaid on the | |||
| image data displayed by the | |||
| software. The Q LAB software | |||
| provides a means of analyzing | |||
| the content of the image data | |||
| contained within the ROI figure. | The Volcano Therapeutics, Inc. | ||
| Volcano IVUS System is | |||
| intended to be used in | |||
| conjunction with imaging | |||
| catheters during diagnostic | |||
| ultrasound imaging of the | |||
| peripheral and coronary | |||
| vasculature. The Volcano IVUS | |||
| System is intended to | |||
| semi-automatically visualize | |||
| boundary features and | |||
| perform spectral analysis of RF | |||
| ultrasound signals of vascular | |||
| features that the user may |
| Table 1.6.1 – The substantial equivalence comparison table |
|---|
| ------------------------------------------------------------ |
7
Image /page/7/Picture/0 description: The image shows the logo for AmCad BioMed Corporation. The logo consists of a blue stylized letter "A" with a circle inside it, followed by the company name in both Chinese and English. The Chinese name is "安克生醫股份有限公司", and the English name is "AmCad BioMed Corporation". The text is in a clear, bold font.
| Table 1.6.1 The substantial equivalence comparison table | |||
|---|---|---|---|
| Device | Proposed Device | Primary Predicate Device | Reference Device |
| AmCAD-US | Q LAB Quantification Software | The software used on Volcano | |
| IVUS System | |||
| parametric images of | |||
| backscattered statistics. | |||
| The color-coded parametric | |||
| images of the backscattered | |||
| statistics signals may be | |||
| useful in assisting the | |||
| assessment of tissue states | |||
| of any scanned tissues. The | |||
| histogram view of the data | |||
| provides a different view to | |||
| accommodate the variation | |||
| in tissue compositions. | The Q LAB software provides a | ||
| means of presenting the ROI | |||
| data in an XY graphic format. | |||
| The Q LAB software provides a | |||
| means to perform a curve fit | |||
| operation on a data set | |||
| generated by the ROI analysis | |||
| software. The Q LAB software | |||
| provides a means of exporting | |||
| the data generated by the plugin | |||
| modules in a form accessible to | |||
| the end user. | wish to examine more closely | ||
| during routine diagnostic | |||
| ultrasound imaging | |||
| examinations. | |||
| Functional | |||
| Capability | AmCAD-US is a software | ||
| package designed to | |||
| quantify and visualize the | |||
| backscatter statistics | |||
| contained in ultrasound | |||
| image data obtained from | |||
| an FDA-cleared general | |||
| purpose ultrasound system. | |||
| The device provides dual | |||
| mode images, including | |||
| conventional B-mode | |||
| ultrasound image in grav | QLAB is a software application | ||
| that is available either as a | |||
| stand-alone product that can | |||
| function on a standard PC, a | |||
| dedicated workstation, and | |||
| on-board Philips' ultrasound | |||
| systems. It can be used for the | |||
| on-line and off-line review and | |||
| quantification of ultrasound | |||
| studies. | |||
| The Region of Interest | |||
| Quantification (ROI) Q-App is a | The second software program | ||
| is called IVUSLabVH. This | |||
| program analyzes each of the | |||
| slices. These images are | |||
| visually reviewed and the | |||
| control points are manually | |||
| adjusted until they appear in | |||
| the proper location on the | |||
| vessel inner and outer borders. | |||
| Once all the control points | |||
| have been properly located | |||
| the software produces a set of | |||
| Device | Proposed Device | Primary Predicate Device | Reference Device |
| AmCAD-US | Q LAB Quantification Software | The software used on Volcano | |
| IVUS System | |||
| scale and color-mapped US | |||
| (ultrasound structure) | |||
| mode image. The US-mode | |||
| provides a means for | |||
| viewing and displaying the | |||
| backscatter statistical | |||
| values. The device uses | |||
| parametric model or | |||
| nonparametric statistics | |||
| that best describes the | |||
| distribution curve of the | |||
| backscattered signals. The | |||
| parameters vary by the US | |||
| method (backscattered | |||
| statistics) selected. The | |||
| preferences include options | |||
| to set the parameters | |||
| mapped onto the image | |||
| and US method options | |||
| applied to the data. The | |||
| user can also select a | |||
| specific region of interest | |||
| (ROI) on the image for | |||
| quantification analysis. | tool for analyzing the image | ||
| pixel content and the time or | |||
| intensity data in the image. | |||
| The analysis can display the | |||
| mean, median, standard | |||
| deviation, flow index, vascularity | |||
| index, vascularity flow index, | |||
| and pixel intensity index for | |||
| echo, color, and power images. | |||
| Within the ROI drawn on the | |||
| image, the mean and median | |||
| pixel intensity values are | |||
| calculated for each frame of the | |||
| sequence in the image file. For | |||
| each mean intensity value | |||
| calculated, the standard | |||
| deviation is calculated. If the | |||
| exported data contains a single | |||
| frame, the mean intensity is a | |||
| single data point. If the exported | |||
| data contains multiple frames, | |||
| the mean intensity is graphed as | |||
| a curve over time with a data | |||
| point for each frame. | data files called "snaxel" files | ||
| which define the coordinates | |||
| of the control points. The black | |||
| and white IVUS files and the | |||
| snaxel files are loaded into the | |||
| IVUSLabVH software which | |||
| processes the data to produce | |||
| the five color bit mapped | |||
| Volcano IVUS image files. The | |||
| software uses radiofrequency | |||
| backscatter analysis of IVUS | |||
| data and produces | |||
| characterization of different | |||
| tissue types. | |||
| Device | Proposed Device | Primary Predicate Device | Reference Device |
| AmCAD-US | Q LAB Quantification Software | The software used on Volcano | |
| IVUS System | |||
| AmCAD-US has a data | |||
| export function to record | |||
| and save the analysis | |||
| results. | (derived from QLAB user | ||
| manual ) | |||
| Input (format) | RF or envelope data in two | ||
| dimensional matrix. | Image data of proprietary | ||
| machine. | Raw data (containing RF | ||
| signals) of proprietary | |||
| machine. | |||
| Output (format) | The software can export | ||
| the data generated by the | |||
| analysis of the image data | |||
| in both text and image | |||
| formats accessible to the | |||
| users. The text format file | |||
| contains the statistical | |||
| value and histogram data. | |||
| The image format file (.bmp | |||
| or .jpeg) contains the | |||
| processed image or data | |||
| visualization as shown on | |||
| the user interface. The | |||
| output information is the | |||
| backscattered statistics | |||
| (distribution-related | |||
| statistics) rendered with | The software can export the | ||
| data generated by the plugin | |||
| modules in a form accessible to | |||
| the end user. The output | |||
| information includes the | |||
| descriptive statistics within a | |||
| user-selected ROI and the | |||
| specific indices defined by the | |||
| software. | |||
| The quantified values are | |||
| rendered with color codes. The | |||
| color-coded image is then | |||
| superimposed on the sonogram. | |||
| The below exemplar image | |||
| shows the color-coded overlay | |||
| image and the trend | The five color bit-mapped | ||
| Volcano IVUS image files. The | |||
| software processes the data | |||
| and produces the five color bit | |||
| mapped based on the | |||
| quantified values of | |||
| backscatter RF analysis and the | |||
| classified outputs. | |||
| Device | Proposed Device | Primary Predicate Device | Reference Device |
| AmCAD-US | Q LAB Quantification Software | The software used on Volcano | |
| IVUS System | |||
| color codes for visualization | |||
| and descriptive statistics of | |||
| ultrasound backscattered | |||
| data. The below exemplar | |||
| image shows the | |||
| color-coded overlay image | |||
| and the histogram provided | |||
| by the software. | chart/descriptive statistics | ||
| provided by the software. | |||
| Example | Image: Ultrasound image with color codes and histogram | Image: Q LAB Quantification Software | Image: Volcano IVUS System |
| Tools provided by | Statistical analysis based on | Strain analysis, ROI statistics of | Spectrum analysis of |
| the device | RF data, ROI statistics, | ||
| distance measurement, | image data, distance | ||
| measurement, data export, etc. | backscattered RF data, ROI | ||
| statistics, distance | |||
| data export. | measurement, etc. | ||
| Software Design | Based on statistical analysis | Based on ROI analysis of the | Perform radiofrequency (RF) |
| of ultrasound backscattered | image data | spectral analysis of ultrasound |
8
Image /page/8/Picture/0 description: The image shows the logo of AmCad BioMed Corporation. The logo consists of a blue symbol on the left and the company name in both Chinese and English on the right. The English name is "AmCad BioMed Corporation", and the Chinese name is "
安克生醫股份有限公司". The symbol is a stylized blue shape.
9
Image /page/9/Picture/0 description: The image contains the logo for AmCad BioMed Corporation. The logo consists of a blue stylized letter "A" with a circle inside it, followed by the company's name in both Chinese and English. The Chinese name is "安克生醫股份有限公司", and the English name is "AmCad BioMed Corporation".
10
Image /page/10/Picture/0 description: The image contains the logo and name of AmCad BioMed Corporation. The logo is a blue stylized letter "A" with a circle containing the letter "C" at the top. The name of the company is written in both Chinese and English, with the Chinese characters appearing above the English text. The Chinese characters read "安克生醫股份有限公司".
11
Image /page/11/Picture/0 description: The image shows the logo for AmCad BioMed Corporation. The logo consists of a blue stylized letter "A" with a circle inside it, followed by the company name in both Chinese and English. The Chinese name is "安克生醫股份有限公司", and the English name is "AmCad BioMed Corporation".
| Device | Proposed Device | Primary Predicate Device | Reference Device |
|---|---|---|---|
| AmCAD-US | Q LAB Quantification Software | The software used on Volcano | |
| IVUS System | |||
| signals contained in the | |||
| image data and statistical | |||
| analysis in image data | backscattered signals | ||
| Operating System | Standard PC Operating | ||
| System | Same | Same |
12
Image /page/12/Picture/0 description: The image shows the logo and contact information for AmCad BioMed Corporation. The logo features a blue stylized letter "C" and a building-like shape. The text includes the company name in both Chinese and English, followed by the address: FL.3, NO.167, Fu Hsing N. RD., Taipei 105, Taiwan, ROC. The telephone number is +886-2-27136227 and the fax number is +886-2-27152181.
1.7 Performance Standards
No performance standards for PACS systems or components have been issued under the authority of Section 514.
1.8 General Safety and Effectiveness Concerns
Software development for the AmCAD-US follows documented processes for software design, verification and validation testing. A risk assessment has been completed to identify potential design hazards that could cause an error or injury based on the use of the quantification results. Appropriate steps have been taken to control all identified risks for this type of image viewing and quantification device. The device labeling contains operating instructions for use and necessary warnings and notes to provide the safe and effective use of the AmCAD-US.
1.9 Performance Data
The following performance data were provided in support of the substantial equivalence determination.
Verification Tests:
AmCad BioMed Corporation has conducted the software verification tests, including software unit test, software integration test, and software system test, to evaluate the safety and effectiveness of AmCAD-US. The software verification testing was performed to ensure that AmCAD-US meets all functional and specifications for its indication for use.
Non-clinical Validation Tests:
The performance validation tests, including the phantom study, animal study, and human tissue validation study, were performed to validate the performance of the AmCAD-US for its intended use.
13
Image /page/13/Picture/0 description: The image shows the logo and contact information for AmCad BioMed Corporation. The logo features a blue stylized letter "C" inside a blue shape resembling a house. Below the logo is the company name in both Chinese and English. The address is listed as FL.3, NO.167, Fu Hsing N. RD., Taipei 105, Taiwan, ROC, and the telephone number is +886-2-27136227, while the fax number is +886-2-27152181.
● Phantom Study
In the phantom study, AmCAD-US was applied to cell phantoms with different concentrations of one cell type and with different constitutions of mixed cell types. The results of this study demonstrate the utility of the device in analyzing various cell compositions.
● Animal Study
In the animal study, AmCAD-US was applied on 6 rats with liver fibrosis induced by dimethylnitrosamine (DMN) injection. The results of this study demonstrate a strong correlation between the backscattered statistics provided by the device and the dosage of DMN injections. This study also demonstrates the utility of the device in analyzing the variation of the tissue compositions in small animals.
● Human tissue validation study
In the human tissue validation study, two common ultrasound scanning modes, e.g. thyroid and abdomen modes, were applied to demonstrate the utility of proposed device in analyzing backscattered-signal distribution of tissue compositions in the human body. In addition, two different FDA-cleared ultrasound systems were used in this study. The result of this study indicated that the device could be applied to various tissue parts in the human body and can be used with RF/Envelop data provided by various FDA-cleared ultrasound systems.
Clinical Validation Tests:
The subject of this 510(k) notification, AmCAD-US, did not require clinical studies to support safety and effectiveness of the software.
1.10 Conclusions
The software development for AmCAD-US followed documented processes for software design, software verification testing, and performance validation testing. A risk assessment has been completed to identify potential design hazards that could cause an error or injury based on the use of the quantification results. Appropriate steps have been taken to control all identified risks for the device. There is no known direct safety or health risk caused by, or related to, the use of the device. The safety and effectiveness of the device has been described in detail in the verification and
14
Image /page/14/Picture/0 description: The image shows the logo and contact information for AmCad BioMed Corporation. The logo features a stylized blue "A" with a "C" inside the top portion. Below the logo is the company name in both Chinese and English. The address is listed as FL.3, NO.167, Fu Hsing N. RD., Taipei 105, Taiwan, ROC, and the telephone number is +886-2-27136227, while the fax number is +886-2-27152181.
validation document.
The data presented in this 510(k) application demonstrates that the proposed device, AmCAD-US, is as safe and effective as the primary predicate device. The intended use of AmCAD-US is similar to the primary predicate device. The technological differences do not raise any new questions regarding the safety and effectiveness of the device and the secondary referenced device is listed to reference the similar technological characteristics as that of the proposed device. Thus, AmCAD-US is substantially equivalent to the predicate device as a software device intended to view and quantifying the ultrasound image data. Both devices are classified as Picture Archiving and Communication Systems, 21 CFR 892.2050.